Evidence map›Paper›PMID 26398938›Full record

ArticleDisease models & mechanisms2015

A zebrafish larval model reveals early tissue-specific innate immune responses to Mucor circinelloides.

Kerstin Voelz, Remi L Gratacap, Robert T Wheeler

Open access · goldAbstract readComparative Study
In one paragraph

Article in Disease models & mechanisms, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Molecular mechanisms that govern infection and antifungal resistance in Mucorales.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  6. Article
  7. Review
  8. AlternativeFrontiers in cellular and infection microbiology · 2024
    Review
  9. Article
  10. Journal of fungi (Basel, Switzerland) · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Journal of immunotoxicology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Kerstin VoelzInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham B15 2TT, UK Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA National Institute of Health Research Surgical Reconstruction and Microbiology Research Centre, Queen Elizabeth Hospital, Birmingham B15 2TH, UK k.voelz@bham.ac.uk.
Remi L GratacapDepartment of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.
Robert T WheelerDepartment of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.
University of Maine · USNIHR Surgical Reconstruction and Microbiology Research Centre · GB

Funding

The Maine Biomedical Research Network (INBRE)P20GM103423 · NIGMS · MOUNT DESERT ISLAND BIOLOGICAL LAB · PI Dustin Lynn Updike · 2012 to 2026
$60.0M
NIGMS NIH HHS P20 GM103423Wellcome TrustWellcome Trust 175ISSFPP
6 · The paper itself

Abstract

Mucormycosis is an emerging fungal infection that is clinically difficult to manage, with increasing incidence and extremely high mortality rates. Individuals with diabetes, suppressed immunity or traumatic injury are at increased risk of developing disease. These individuals often present with defects in phagocytic effector cell function. Research using mammalian models and phagocytic effector cell lines has attempted to decipher the importance of the innate immune system in host defence against mucormycosis. However, these model systems have not been satisfactory for direct analysis of the interaction between innate immune effector cells and infectious sporangiospores in vivo. Here, we report the first real-time in vivo analysis of the early innate immune response to mucormycete infection using a whole-animal zebrafish larval model system. We identified differential host susceptibility, dependent on the site of infection (hindbrain ventricle and swim bladder), as well as differential functions of the two major phagocyte effector cell types in response to viable and non-viable spores. Larval susceptibility to mucormycete spore infection was increased upon immunosuppressant treatment. We showed for the first time that macrophages and neutrophils were readily recruited in vivo to the site of infection in an intact host and that spore phagocytosis can be observed in real-time in vivo. While exploring innate immune effector recruitment dynamics, we discovered the formation of phagocyte clusters in response to fungal spores that potentially play a role in fungal spore dissemination. Spores failed to activate pro-inflammatory gene expression by 6 h post-infection in both infection models. After 24 h, induction of a pro-inflammatory response was observed only in hindbrain ventricle infections. Only a weak pro-inflammatory response was initiated after spore injection into the swim bladder during the same time frame. In the future, the zebrafish larva as a live whole-animal model system will contribute greatly to the study of molecular mechanisms involved in the interaction of the host innate immune system with fungal spores during mucormycosis.

Indexed as

Immunity, InnateAir SacsAnimalsCentral Nervous System Fungal InfectionsDisease Models, AnimalHost-Pathogen InteractionsImmunosuppressive AgentsInflammation MediatorsLarvaMacrophagesMucorMucormycosisNeutrophilsPhagocytosisRhombencephalonTime FactorsImmunosuppressive AgentsInflammation MediatorsDanio rerioInnate immune systemMacrophagesMucor circinelloidesMucormycosisNeutrophilsPhagocytesZebrafish larva

Identifiers

PMID26398938
PMCPMC4631785
OpenAlexW2402107045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.